PMS17 - Cost Per-Responder Analysis of Secukinumab Compared To Other Biologics For The Treatment of Psoriatic Arthritis In Saudi Arabia

Journal article

Open access

Peer reviewed

H Al Hamdan, M Al Howimel, K Al Jufan, H Al Mudaiheem, A AlAlwan, N Alshehri, N Zakaria, L Al Kateb and G Ramakrishna

Value in health, Vol.21, pp.S82-S82

09/2018

Files and links (1)

url

https://doi.org/10.1016/j.jval.2018.07.610View

Published (Version of record) Open

1 Record Views

Title: PMS17 - Cost Per-Responder Analysis of Secukinumab Compared To Other Biologics For The Treatment of Psoriatic Arthritis In Saudi Arabia
Creators - without role: H Al Hamdan - King Abdulaziz Medical City
M Al Howimel - National Guard Health Affairs
K Al Jufan - National Guard Health Affairs
H Al Mudaiheem - Ministry of Health
A AlAlwan - Riyadh Armed Forces Hospital
N Alshehri - Riyadh Armed Forces Hospital
N Zakaria - Novartis, Riyadh, Saudi Arabia
L Al Kateb - Novartis, Riyadh, Saudi Arabia
G Ramakrishna - Novartis
Publication Details: Value in health, Vol.21, pp.S82-S82
Publisher: Elsevier Inc
Identifiers: 9920676508331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article